#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Optic glioma Focal segmental glomerulosclerosis Mixed-type liposarcoma Leukaemia Short stature Fabry's disease Parkinson's disease Thrombocytopenia Pancreatic carcinoma metastatic Leber's congenital amaurosis Extra-osseous Ewing's sarcoma Encephalitis autoimmune Haemophilia B without inhibitors KBG syndrome Osteomyelitis More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Basic Information Sarcoma Noonan syndrome – Trials in Disease Mucopolysaccharidosis – Treatment Myxofibrosarcoma MELAS syndrome – Trials in Disease Amyotrophic lateral sclerosis – Life with Disease Progressive supranuclear palsy – Treatment Leiomyosarcoma – Basic Information Waldenstrom’s macroglobulinaemia refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mercaptopurine Hydrochlorothiazide Nepafenac CHONDROITIN SULFATE SODIUM Pf-06835375 Magnesium Citrate Gandotinib Ziclumeran GSKVX000000034796 Denosumab Bi 1015550 Fludrocortisone Theophylline Immunglobulin GSKVX000000017986 Vamorolone Glyceryl Trinitrate Irinotecan Glipizide Prx005 More therapies…

    Learn about Your Condition

    Osteoarthritis Acute cardiac event Arthritis infective Endotracheal intubation Escherichia infection Diverticulitis Alcohol abuse Testicular leiomyosarcoma Nephropathy Non-Hodgkin's lymphoma Acute lymphocytic leukaemia Prolymphocytic leukaemia Paresis Anal fissure Cardiac failure chronic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Title: Comparison of Oral Esketamine versus Electroconvulsive Therapy in Patients with Treatment-Resistant Depression

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Esketamine
    The Netherlands

  • Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Triamcinolone Hexacetonide
    • Certolizumab Pegol
    • Leflunomide
    Denmark Iceland Norway Sweden

  • Study on Cannabidiol as an Add-On Treatment for Patients with Early Schizophrenia

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Cannabidiol
    Germany

  • Study of antibiotic combination therapy duration based on patient response for adults with community-acquired pneumonia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Azithromycin
    • Demeclocycline Hydrochloride
    • Pristinamycin
    France

  • Study on the Effect of Pregabalin on Sleep and Pain in Patients with Neuropathic Pain

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Pregabalin
    Finland

  • Study on Maintenance Therapy with OSE2101 and FOLFIRI for Patients with Advanced Pancreatic Cancer After Initial FOLFIRINOX Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    France
Previous Page
1 … 863 864 865 866 867 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!